By Aled Herbert
Published: 28 April 2000 14:51 GMT
Jan Leschly, CEO of SmithKline Beecham, has become the latest high-profile executive to quit his job and join a dot-com start-up.
Leschly last week joined the board of Chemdex, a US business-to-business company that sells pharmaceutical supplies. The business proposal was made by his son while at university.
At SmithKline's AGM today, Leschly will hand over the CEO reins to JP Garnier, the company's former chief operating officer. Leschly said the move will be a clean split with the company he joined in 1994.
Clinical Trial Supplies Manager SUMMARY Clinical Trial Supplies Manager required by UK-based Pharmaceutical Company. JOB TITLE Clinical Trial ...
Electronics Test & Development Engineer - Power Supply / SMPS - Essex Due to our increasing work-load we are currently looking to recruit a ...
It is envisaged your time will be split equally between the office, and travelling to client sites in order to present the solutions, throughout the ...
Agenda Setters 2009
Welcome to the ninth annual Agenda Setters poll – silicon.com's list of the top 50 most influential individuals in the technology and IT industries, from techies and CIOs to entrepreneurs and business leaders. Find out more in our latest special report.
Is Your Enterprise Architected for Tomorrow's Growth?
Improving IT service delivery through an integrated approach to software asset management...
TechRepublic Resource Guide: Software as a Service (SaaS) for Small and Midsize Businesses...
Download a Free Trial of SmartDraw: Learn why SmartDraw is the ideal alternative...
Stories from the web...
Copyright © 2008 CBS Interactive Limited. All rights reserved. Top of page
Digg
Slashdot
Del.icio.us
Stumble
Reddit
RSS Feeds
Clive Longbottom Windows 7: Not perfect - but ready for prime time Microsoft's latest OS fixes most of Vista's ills - but still has challenges ahead
Stephen Kleynhans Mind the details with Windows 7 Just because it might work better than Vista, it doesn't mean you can be sloppy